{"id":198448,"date":"2024-12-19T15:06:04","date_gmt":"2024-12-19T15:06:04","guid":{"rendered":"https:\/\/news.talkwithrattan.com\/index.php\/2024\/12\/19\/roches-parkinsons-drug-candidate-misses-key-goal-in-mid-stage-study\/"},"modified":"2024-12-19T15:06:05","modified_gmt":"2024-12-19T15:06:05","slug":"roches-parkinsons-drug-candidate-misses-key-goal-in-mid-stage-study","status":"publish","type":"post","link":"https:\/\/news.talkwithrattan.com\/index.php\/2024\/12\/19\/roches-parkinsons-drug-candidate-misses-key-goal-in-mid-stage-study\/","title":{"rendered":"Roche&#039;s Parkinson&#039;s Drug Candidate Misses Key Goal in Mid-Stage Study"},"content":{"rendered":"<div style=\"text-align:center\"><img loading=\"lazy\" decoding=\"async\" width=\"553\" height=\"369\" src=\"https:\/\/i0.wp.com\/images.wsj.net\/im-873951\/medium?resize=553,369&amp;ssl=1\" class=\"attachment-post-thumbnail size-post-thumbnail wp-post-image\" alt=\"Roche&#039;s Parkinson&#039;s Drug Candidate Misses Key Goal in Mid-Stage Study\" title=\"Roche&#039;s Parkinson&#039;s Drug Candidate Misses Key Goal in Mid-Stage Study\" \/><\/div>\n<p>An experimental Parkinson\u2019s drug missed its primary goal in a mid-stage trial, Roche said, in what is the second setback this week for candidate treatments for the neurodegenerative condition.<br \/>\n<br \/><br \/>\n<br \/><a href=\"https:\/\/www.wsj.com\/articles\/roches-parkinsons-drug-candidate-misses-key-goal-in-mid-stage-study-702722d6?mod=pls_whats_news_us_business_f\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>An experimental Parkinson\u2019s drug missed its primary goal in a mid-stage trial, Roche said, in what is the second setback this week for candidate treatments for the neurodegenerative condition. Source link<\/p>\n","protected":false},"author":2,"featured_media":198449,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"tdm_status":"","tdm_grid_status":"","fifu_image_url":"https:\/\/images.wsj.net\/im-873951\/medium","fifu_image_alt":"","footnotes":""},"categories":[604],"tags":[2309,1393,38738,2733,155753,14952,155752,155751,250],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/posts\/198448"}],"collection":[{"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/comments?post=198448"}],"version-history":[{"count":1,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/posts\/198448\/revisions"}],"predecessor-version":[{"id":198450,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/posts\/198448\/revisions\/198450"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/media\/198449"}],"wp:attachment":[{"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/media?parent=198448"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/categories?post=198448"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/tags?post=198448"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}